ADDRESSING FROM THE OUTSIDE
RETILEX-A®-PRO molecules are protected by a proprietary nano-encapsulation delivery system, which helps them to work for longer and penetrate deeper into lesions and hardened skin.
REPLENISHING FROM THE INSIDE
VERCILEX®-F helps replenish integral skin proteoglycans, which are an important part of the skin’s cellular matrix and an important constituent in maintaining the skin’s strength, elasticity, and tissue hydration.
DUAL ACTION TREATMENT
Together, RETILEX-A®-PRO and VERCILEX®-F possess a broad range of synergistic effects and therapeutic benefits as documented in numerous clinical publications.
Psoriasis is a chronic disorder requiring long-term treatment.
That is why it is important to find an approach that minimises side-effects and complications. This is particularly true for most psoriatic patients who have only localised and intermittent flare ups.
RETILEX-A®-PRO in Zymbilan® cream is a next-generation topical retinoid that ensures an effective, safe, and drug-free treatment that can be utilised for longer periods of time – without side effects.
This makes Zymbilan® a novel choice as a first-line therapeutic option or to enhance the efficacy of other conventional therapies over extended periods.
As psoriasis research advances, accumulating evidence points to the promising potential of Proteoglycan Replacement Therapy (PRT) as an innovative and viable treatment form.
Proteoglycans are proteins that play an important role in the skin’s extracellular matrix. When they are deficient or dysfunctional, a condition known as Epidermal Dysglycania (EDG) results.
The resulting imbalance of proteoglycans in the skin triggers a faulty immune response in which the body is, essentially, attacking itself.
Research has shown that the proteoglycans found in Zymbilan®-PRT Tablets help restore and treat cellular and barrier dysfunctions that occur in patients with psoriasis by: